Search research articles
Contact Us
Filters
Showing results (41-50 of 43) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 43 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2018
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results
T Aparicio, O Bouché, J Taieb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results
T Aparicio, O Bouché, J Taieb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2015
Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001-02)
T Aparicio, S Lavau-Denes, J M Phelip, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 43) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 43 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2018
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results
T Aparicio, O Bouché, J Taieb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results
T Aparicio, O Bouché, J Taieb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2015
Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001-02)
T Aparicio, S Lavau-Denes, J M Phelip, et al.
Page
of 5